Skip to main content

CA Supreme Court Refused To Hear Monsanto’s Appeal

CA Supreme Court Refused To Hear Monsanto’s Appeal

CA Supreme Court Refused To Hear Monsanto’s Appeal

Introduction

An $86.7 million settlement awarded to a Livermore couple diagnosed with cancer after years of exposure to Roundup weed killer has been put on hold as the California Supreme Court refused to hear Monsanto’s appeal.

The verdict was declared in May 2019, where both the plaintiffs were awarded $1 billion in punitive damages each in addition to the $55 million combined compensatory damages. The wife even testified that she would not have bought the herbicide if she had known earlier that the approval studies of the weed killer were fraudulent.

As per the jury's verdict about the lawsuit in 2019, Monsanto was found guilty for failing to warn the consumers about the risks associated with the weed killer. The lawsuit even claimed that the company used fraudulent methods to hide the fact that their weed killer caused cancer.

As per the court documents, both the plaintiffs were diagnosed with non-Hodgkin lymphoma because of the decades of Roundup use. The court documents highlighted that the husband was diagnosed with systemically diffused large B-Cell lymphoma in his bones in 2011, and his wife was diagnosed with an aggressive subset of lymphoma in her brain in 2015.

The plaintiffs' attorney stated that the 2019 verdict was based on facts and science. Thus the company should stop using the appeals process to avoid paying the settlement amount to the plaintiffs.

Environmental Protection Agency stated that Roundup's active ingredient glyphosate might not sicken humans, whereas the weed killer has been classified as a “probable human carcinogen” by the International Agency for Research on Cancer in 2015.

Bayer has even promised to discontinue the sale of glyphosate-based products from retail stores by 2023 to avoid future litigations, but still, the company continues to back its Roundup's safety.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!